Cyclenium Pharma Inc
$49,790.00 CAD
≈ 8 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- January 2, 2023 – March 31, 2024
- Reference
- nrc-cnrc:172-2022-2023-Q4-999723
Published purpose
This project is focused on identifying and characterizing highly selective leads for the treatment of a psychological disorder. The latest series of unique compounds will be subjected to thorough in vitro pharmacological investigation to select the best ones for subsequent progression to scale-up and evaluation in a validated animal model.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions